Application
IHC-P analysis of human kidney tissue using CRELD1 antibody at 4.0-8.0μg/ml.Application
WB analysis of HepG2 cells using CRELD1 antibody at 5.0μg/ml. Lane A : marker Lane B : HepG2 cells| Product Name | CRELD1 antibody, C-term |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | Rabbit Polyclonal antibody to CRELD1This gene encodes a member of a subfamily of epidermal growth factor-related proteins. The encoded protein is characterized by a cysteine-rich with epidermal growth factor-like domain. This protein may function as a cell adhesion molecule. Mutations in this gene are the cause of atrioventricular septal defect. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Apr 2010] |
| Immunogen | A synthetic peptide corresponding to a C-terminal region of Human CRELD1 |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | IHC-PWB |
| *Optimal dilutions/concentrations should be determined by the researcher.
: |
|
| Species Reactivity | Human |
| Predicted Reactivity | Cow: 100%; Dog: 100%; Guinea Pig: 100%; Horse: 100%; Human: 100%; Mouse: 86%; Rat: 93% |
| Concentration | 1mg/ml |
| Purification | Protein A |
| Gene Synonyms | CRELD1 CIRRIN AVSD2 |
|---|---|
| Target | CRELD1 |
| Molecular Weight(MW) | 45 KDa (note) |
Application
IHC-P analysis of human kidney tissue using CRELD1 antibody at 4.0-8.0μg/ml.
Application
WB analysis of HepG2 cells using CRELD1 antibody at 5.0μg/ml. Lane A : marker Lane B : HepG2 cells| Positive Control | HepG2 |
|---|---|
| Application Notes | *Optimal dilutions/concentrations should be determined by the researcher.
: |
| Form | Liquid |
|---|---|
| Storage Instructions | Keep as concentrated solution. For short-term storage, store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose. |
